Colorectal cancer screening could be whittled down to a drop of blood
A Belgian startup may offer an alternative to screening colonoscopies – VolitionRx (Opens in a new window)is reporting its single-drop blood test can diagnose 84 percent of colorectal cancers of all stages, with 78 percent specificity. The company just raised $1.1 million.Data from its 938-subject sample of a 4,800 pilot study in Denmark demonstrate the company’s NuQ diagnostic […]